Comprehensive Study Guide for Nuclear Medicine and Radiochemistry

Fundamental Atomic Physics & Radioactivity Concepts

  • Definition of an Atom:

    • An atom is the basic building block of all matter and the smallest particle of an element that retains the chemical identity of that element.

    • Ancient Greek philosophers first predicted the existence of the atom around 500 BC, coining the word from atomos, meaning "undivided".

    • Atoms consist of three primary subatomic particles: protons, neutrons, and electrons.

    • The space between the surrounding electron cloud and the central nucleus is vast; consequently, an atom is 99.9%99.9\% empty space.

    • An atom's chemical identity and atomic number (ZZ) are strictly determined by its number of protons.

  • Subatomic Particles:

    • Protons: Positively charged particles located within the atomic nucleus.

    • Neutrons: Neutral particles located within the nucleus, discovered in 1932 by Sir James Chadwick. A neutron carries no electrical charge and has a mass approximately 18401840 times that of an electron. A free neutron (outside a nucleus) is unstable and undergoes beta decay to form a proton, an electron, and an electron-antineutrino.

    • Electrons: Negatively charged particles orbiting the nucleus in external electron fields.

  • Atomic Stability and Isotopes:

    • Most naturally occurring atoms possess a balanced neutron-to-proton ratio and are chemically and nuclearly stable.

    • Isotopes: Variants of a specific chemical element that contain an identical number of protons but different numbers of neutrons (e.g., Carbon-12 has 6 protons and 6 neutrons; Carbon-13 has 6 protons and 7 neutrons; Carbon-14 has 6 protons and 8 neutrons).

    • Radioisotopes: Versions of a chemical element with unstable nuclei possessing excess energy or an unusual neutron-to-proton ratio. Unstable atoms continuously undergo spontaneous transformation (radioactive decay) to reach a stable nuclear configuration.

Discovery and Early History of Radioactivity

  • Antoine Henri Becquerel (February 1896):

    • Discovered spontaneous radioactivity while investigating whether fluorescent materials produced X-rays.

    • Becquerel worked with a uranium compound that fluoresced when exposed to sunlight. Due to overcast weather in Paris, he stored the uranium sample alongside an undeveloped photographic plate wrapped in black paper inside a dark drawer.

    • Upon developing the plate, he observed it was heavily fogged by radiation emitted spontaneously by the uranium without sunlight stimulation.

    • He demonstrated the penetrating power of these rays by placing a metal Maltese Cross between the uranium salt and the photographic plate, leaving a sharp shadow.

    • Shared the 1903 Nobel Prize in Physics for this discovery.

Becquerel's photographic plate fogged by uranium radiation showing shadow of Maltese Cross
  • Distinction Between Fluorescence, Phosphorescence, and Radioactivity:

    • Fluorescence & X-Rays: Emission of radiation ceases immediately when the initiating energy source is removed.

    • Phosphorescence: Re-emission of absorbed light continues for a period after the external energy source is removed.

    • Spontaneous Radioactivity: Emission of energy occurs continuously and spontaneously from within the atomic nucleus without any external energy input.

  • Marie and Pierre Curie:

    • Coined the term radioactivity.

    • Polonium: Discovered in July 1898; named in honor of Marie Curie's native homeland, Poland.

    • Radium: Discovered in December 1898.

    • Conducted painstaking chemical purifications of pitchblende in a makeshift laboratory described as a "miserable hangar" or "potato cellar" where winter temperatures fell to 6∘C6^\circ\text{C}.

    • Refused to file patents on radium extraction processes, believing scientific discoveries should be freely available to the global scientific community.

    • Pierre Curie tested radium directly on his own skin, causing a severe burn and subsequent chronic wound, proving its biological activity and giving birth to target radiation therapy (Curietherapy).

    • Founded the Radium Institute through the University of Paris and the Pasteur Institute in 1914.

  • Pioneer Health Impacts and Deaths:

    • Pierre Curie: Died tragically in Paris on April 19, 1906, after being struck by a horse-drawn wagon during a rainstorm on Rue Dauphine, sustaining fatal skull fractures.

    • Marie Curie: Died in July 1934 from aplastic anemia/leukemia resulting from prolonged, unshielded exposure to extreme levels of ionizing radiation, leaving her with severely burned fingers and near-blindness.

Commercial Misuse of Radium and the Radium Girls

  • The Radium Quackery Era (1898–1920s):

    • Following its discovery, radium was marketed commercially as a miraculous health tonic and cure-all for conditions ranging from lupus, scrofula, and skin ulcers to cancer.

    • Commercial products included:

    • Revigator (ca. 1920–1925): A large pottery crock lined with radium ore. Users were instructed to fill it with water overnight and drink 6 or more glasses daily.

    • Vita Radium Suppositories: A 15-day course guaranteed to contain refined radium.

    • Twenty-First Century Bourbon Whiskey: Advertised as aged 30 days by atomic radiation (equivalent to 40 years of standard aging) at 150 proof, with every bottle tested by a Geiger counter.

    • Laine Oradium: Radioactive wool advertised for infant clothing to promote cellular excitation and organic stimulation.

    • Consumer Goods: Radium-branded cigarettes, hand cleaners ("takes off everything but the skin"), bug sprays, boot polishes, and radioactive salves.

  • The Radium Dial Painters ("Radium Girls"):

    • In the late 1910s and 1920s, young women were employed in factories to paint luminous watch and instrument dials using radium-containing paint.

    • Workers routinely used a technique called "lip-pointing," pressing the brush tips between their lips to form a fine point, ingesting small amounts of Radium-226 (226Ra^{226}\text{Ra}) with every dial.

    • Pathophysiology: Radium is an alpha-particle emitter chemically analogous to calcium. It acts as a "bone seeker," depositing directly into the bone matrix and bone marrow.

    • Chronic internal alpha irradiation led to severe jaw necrosis ("radium jaw"), bone fractures, osteosarcoma, severe anemia, and genetic degradation.

  • Legal and Labor Legacy:

    • The lawsuit brought by the Radium Girls established historic legal precedents, securing the right of individual workers to sue employers for occupational labor abuses and disease.

    • Led directly to the establishment of modern occupational health safety standards, labor regulations, and the field of Health Physics.

Nuclear Decay Dynamics and Half-Life Calculations

  • Radioactive Decay Mechanics:

    • Decay occurs spontaneously as an unstable nucleus releases particles or electromagnetic energy to achieve lower energy stability.

    • If the decay alters the number of neutrons, an isotope of the same element is produced.

    • If the decay alters the number of protons (ΔZ≠0\Delta Z \neq 0), the atom transmutes into an entirely different chemical element.

  • Uranium-238 (238U^{238}\text{U}) Decay Chain (Main Branch):   U-238→α4.468×109 yrTh-234→β−24.1 dPa-234m→β−1.17 minU-234→α245,000 yrTh-230→α75,400 yrRa-226\text{U-238} \xrightarrow[\alpha]{4.468 \times 10^9\,\text{yr}} \text{Th-234} \xrightarrow[\beta^-]{24.1\,\text{d}} \text{Pa-234m} \xrightarrow[\beta^-]{1.17\,\text{min}} \text{U-234} \xrightarrow[\alpha]{245,000\,\text{yr}} \text{Th-230} \xrightarrow[\alpha]{75,400\,\text{yr}} \text{Ra-226}   Ra-226→α1600 yrRn-222→α3.82 dPo-218→α3.11 minPb-214→β−26.8 minBi-214→β−19.9 minPo-214\text{Ra-226} \xrightarrow[\alpha]{1600\,\text{yr}} \text{Rn-222} \xrightarrow[\alpha]{3.82\,\text{d}} \text{Po-218} \xrightarrow[\alpha]{3.11\,\text{min}} \text{Pb-214} \xrightarrow[\beta^-]{26.8\,\text{min}} \text{Bi-214} \xrightarrow[\beta^-]{19.9\,\text{min}} \text{Po-214}   Po-214→α163 μsPb-210→β−22.3 yrBi-210→β−5.01 dPo-210→α138 dPb-206 (Stable)\text{Po-214} \xrightarrow[\alpha]{163\,\mu\text{s}} \text{Pb-210} \xrightarrow[\beta^-]{22.3\,\text{yr}} \text{Bi-210} \xrightarrow[\beta^-]{5.01\,\text{d}} \text{Po-210} \xrightarrow[\alpha]{138\,\text{d}} \text{Pb-206 (Stable)}

  • The Three Definitions of Half-Life:

    • Radioactive (Physical) Half-Life (TpT_p or T1/2T_{1/2}): The precise time interval required for exactly half of the unstable nuclei in a sample to undergo decay.

    • Americium-241: 458 years458\,\text{years} (used in ionization smoke detectors)

    • Americium-243: 7370 years7370\,\text{years}

    • Carbon-14: 5730 years5730\,\text{years}

    • Uranium-238: 4.468×109 years4.468 \times 10^9\,\text{years}

    • Iodine-123: 13.2 hours13.2\,\text{hours}

    • Technetium-99m: 6.0 hours6.0\,\text{hours}

    • Iodine-139: 2.0 seconds2.0\,\text{seconds}

    • Biological Half-Life (TbT_b): The time required for the body to eliminate half of an administered substance through biological excretion processes (renal, fecal, pulmonary, perspiration).

    • Effective Half-Life (TeT_e): The net clearance time resulting from both physical radioactive decay and biological elimination:     1Te=1Tp+1Tb  ⟹  Te=Tp×TbTp+Tb\frac{1}{T_e} = \frac{1}{T_p} + \frac{1}{T_b} \quad \implies \quad T_e = \frac{T_p \times T_b}{T_p + T_b}

Nuclear Fission, Chain Reactions, and History

  • Fission Physics:

    • In 1938–1939, Otto Hahn and Fritz Strassmann demonstrated nuclear fission: splitting a heavy target nucleus (such as Uranium-235) by neutron bombardment into smaller fission fragments, releasing binding energy and free thermal neutrons.

Diagram showing nuclear fission of a target nucleus producing fission products and free neutrons
  • Nuclear Chain Reactions:

    • Occurs when free neutrons released during an initial fission event strike adjacent fissionable nuclei, triggering secondary fission events in an exponential cascade.

    • Controlled Chain Reaction: Neutrons are absorbed to maintain a steady energy output (e.g., commercial nuclear power reactors).

    • Uncontrolled Chain Reaction: Neutrons multiply exponentially within milliseconds, yielding a massive explosive detonation (nuclear weapons).

  • Chicago Pile-1 (December 2, 1942):

    • Led by Enrico Fermi beneath the West Stands of Stagg Field at the University of Chicago.

    • Built as an "Atomic Pile" of graphite blocks and uranium, achieving the world's first self-sustaining, controlled nuclear chain reaction.

  • The Manhattan Project & Weapons Development:

    • Trinity Test (July 16, 1945, at 5:29:45 AM MWT): The first detonation of an atomic device ("Gadget"). The thermal energy fused desert sand into a green silicate glass termed Trinitite.

    • Little Boy (Hiroshima - August 6, 1945): Gun-type nuclear weapon utilizing Uranium-235. Detonation required firing one subcritical piece of U-235 into another at high speed to form a supercritical mass.

    • Fat Man (Nagasaki - August 9, 1945): Implosion-type nuclear weapon utilizing Plutonium-239.

    • Weapons efficiency was extremely low; scientists estimate both weapons converted only ≈0.1%\approx 0.1\% (110th\frac{1}{10\text{th}} of 1%1\%) of their total nuclear explosive capacity.

  • Nuclear Disasters and Poisoning Incidents:

    • Three Mile Island (TMI-2) Accident (March 28, 1979): Worst commercial nuclear accident in US history; partial reactor core meltdown in Pennsylvania.

    • Chernobyl Incident (April 26, 1986): Catastrophic core explosion in Ukraine.

    • Polonium-210 Lethal Poisoning (2006): Former Russian agent Alexander Litvinenko was assassinated in London via ingested Polonium-210 (210Po^{210}\text{Po}). Polonium-210 is an intense alpha emitter, estimated to be 2.5×10112.5 \times 10^{11} (250 billion250\,\text{billion}) times more lethal than hydrogen cyanide.

Physics of Radiation and Radiation Interaction

  • Types of Ionizing Radiation:

    • Alpha Particles (α\alpha): Heavy helium nuclei (24He2+^4_2\text{He}^{2+}). High linear energy transfer (LET), low penetration depth; stopped by a single sheet of paper or human epidermis.

    • Beta Particles (β−,β+\beta^-, \beta^+): High-speed electrons (β−\beta^-) or positrons (β+\beta^+). Moderate penetration; stopped by thin aluminum shielding.

    • Gamma Rays (γ\gamma) & X-Rays: High-energy electromagnetic photons traveling at the speed of light (c=3.00×108 m/sc = 3.00 \times 10^8\,\text{m/s}). Highly penetrating; requiring thick lead or dense concrete shielding.

    • Neutrons (n0n^0): Uncharged particulate radiation; stopped by hydrogenous materials (water, paraffin) or thick structural concrete.

  • Origin Comparison: Gamma Rays vs. X-Rays:

    • Gamma Rays: Originate entirely from within the unstable atomic nucleus during nuclear de-excitation transitions.

    • X-Rays: Originate outside the nucleus within electron orbital shells (characteristic X-rays) or via electron deceleration near a nucleus (Bremsstrahlung).

Principles of Nuclear Medicine and Radiopharmaceuticals

  • Physiologic vs. Anatomic Imaging:

    • Anatomic Modalities (X-Ray, CT, MRI, Ultrasound): Evaluate structural morphology, spatial boundaries, and physical tissue density.

    • Nuclear Medicine (Physiologic/Molecular Imaging): Evaluates functional metabolic pathways, organ perfusion, cellular biochemistry, and clearance kinetics. Diagnostic radiopharmaceuticals concentrate based on physiological organ affinity.

  • Diagnostic vs. Therapeutic Milestones:

    • 1936: First human therapeutic application of an artificial radioisotope (32P^{32}\text{P} - Phosphorus-32) to treat chronic leukemia.

    • 1937: First diagnostic use of Iodine-131 (131I^{131}\text{I}) to evaluate thyroid physiology using a Geiger counter.

    • December 7, 1946: Dr. Sam Seidlin published landmark paper in the Journal of the American Medical Association (JAMA) detailing complete cure of metastatic thyroid carcinoma using Iodine-131.

  • Technetium-99m (99mTc^{99\text{m}}\text{Tc}) and the Molybdenum Cow:

    • Introduced in 1957; used in over 80%80\% of all diagnostic nuclear medicine procedures globally.

    • Nuclear Properties: Pure gamma emitter (140 keV140\,\text{keV} photon energy), no beta emissions, physical half-life Tp=6.0 hoursT_p = 6.0\,\text{hours}.

    • Generator Production ("Molybdenum Cow", 1959):

    • Fission of Uranium-235 (235U^{235}\text{U}) yields Molybdenum-99 (99Mo^{99}\text{Mo}, Tp=66 hoursT_p = 66\,\text{hours}) at a 6%6\% reaction yield.

    • Molybdenum-99 is adsorbed as molybdate onto an alumina column inside a lead and depleted-uranium shielded housing.

    • Decaying 99Mo^{99}\text{Mo} forms 99mTc^{99\text{m}}\text{Tc}. Eluting ("milking") the column with 0.9%0.9\% sterile saline (NaCl\text{NaCl}) washes off soluble Sodium Pertechnetate (Na99mTcO4\text{Na}^{99\text{m}}\text{TcO}_4).

    • Clinical Trade-offs:

    • Advantages: High photon yield, optimal energy for detection (140 keV140\,\text{keV}), low patient radiation absorbed dose (1/1000th the radiation dose of I-131 for thyroid scans).

    • Disadvantages: Free pertechnetate concentrates non-specifically in stomach, colon, salivary glands, mucous membranes, and bladder; short half-life requires tight delivery schedules.

  • Common Technetium-99m Radiopharmaceuticals:

    • Lung Perfusion: 99mTc^{99\text{m}}\text{Tc}-Macroaggregated Albumin (MAA)

    • Liver & Spleen: 99mTc^{99\text{m}}\text{Tc}-Sulfur Colloid

    • Skeletal System: 99mTc^{99\text{m}}\text{Tc}-Methylene Diphosphonate (MDP)

    • Brain Perfusion: 99mTc^{99\text{m}}\text{Tc}-HMPAO or Glucoheptonate

    • Myocardial Perfusion: 99mTc^{99\text{m}}\text{Tc}-Sestamibi (Cardiolite) or Tetrofosmin (Myoview)

    • Renal Function/Structure: 99mTc^{99\text{m}}\text{Tc}-MAG3, DTPA, or DMSA

    • Hepatobiliary/Gallbladder: 99mTc^{99\text{m}}\text{Tc}-Disofenin / Mebrofenin (HIDA)

Nuclear Medicine Instrumentation and Mechanics

  • Historical Evolution of Imaging Systems:

    • Rectilinear Scanner (1950 - Benedict Cassen): Mechanically moved a shielded single detector back and forth over a patient to produce a static 2D density print.

    • Scintillation Camera ("Anger Camera" - 1952–1958 by Hal Anger): Stationary wide-field camera utilizing a large single NaI crystal backed by a hexagonal PMT array, enabling real-time functional dynamic imaging.

  • Component Architecture of a Modern Gamma Camera:

    1. Collimator: Heavy lead plate pierced by thousands of microscopic parallel, converging, or pinhole channels. Filters out oblique scattered photons, allowing only gamma rays parallel to hole axes to strike the detector.

    • Pinhole Collimators: Used for high-resolution imaging of small focal organs (e.g., thyroid gland).

    1. Scintillation Detector Crystal: Thallium-doped Sodium Iodide [NaI(Tl)\text{NaI(Tl)}] crystal. Converts absorbed gamma-ray energy into a flash of visible light (scintillation) proportional in intensity to the photon energy.

    2. Photomultiplier Tube (PMT) Array: Hexagonal matrix of vacuum tubes situated behind the crystal. Each PMT converts visible scintillations into photoelectrons via a photocathode, amplifying the signal up to 10810^8 (100 million100\,\text{million}) times across internal dynodes.

    3. Positioning Logic Circuits & Processing Units: Calculates spatial (X,Y)(X, Y) coordinates of each scintillation by taking a weighted spatial average of all PMT pulse amplitudes. Pulse height analyzers (ZZ channel) reject scattered low-energy photons.

    4. Display Terminal: Displays spatial coordinates as gray-scale or color pixels forming digital image frames.

  • Hot Spots vs. Cold Spots:

    • Hot Spots: Areas of increased radionuclide uptake representing hypermetabolism, hyperperfusion, or heightened bone turnover (e.g., osteolytic/osteoblastic metastases, active fractures, inflammatory sites).

    • Cold Spots: Areas of diminished radionuclide uptake representing focal tissue ischemia, cell necrosis, or non-functioning tissue (e.g., acute myocardial infarction, cystic lesions, cold thyroid nodules).

SPECT, PET, and Advanced Hybrid Imaging

  • Single Photon Emission Computed Tomography (SPECT):

    • Utilizes one, two, or three Anger gamma camera heads rotating 360∘360^\circ around the patient to capture sequential 2D projections.

    • Computer algorithms reconstruct raw planar projections into 3D cross-sectional tomographic slices along transaxial (axial), coronal, and sagittal planes.

    • Primary Tracers: 99mTc^{99\text{m}}\text{Tc}, Iodine-123 (123I^{123}\text{I}), Thallium-201 (201Tl^{201}\text{Tl}), Xenon-133 (133Xe^{133}\text{Xe}).

  • Positron Emission Tomography (PET):

    • Utilizes short-lived positron-emitting radioisotopes produced in an onsite particle accelerator (Cyclotron).

    • Positron Annihilation Physics: An unstable proton-rich nucleus emits a positron (β+\beta^+). The positron travels a short distance (<1 mm<1\,\text{mm}) before colliding with a tissue electron (e−e^-). Their mutual annihilation converts their mass entirely into two 511 keV511\,\text{keV} gamma photons emitted simultaneously (180∘180^\circ opposite directions).

    • Coincidence Detection: Rings of detector crystals register true coincidence events when two 511 keV511\,\text{keV} photons strike diametrically opposed detectors within a narrow time window (nanoseconds), forming a straight line-of-response (LOR).

Diagram showing positron annihilation with an electron emitting twin 511 keV photons in opposite directions
  • The Cyclotron Acceleration Mechanism:

    • Charged ions (e.g., protons) are injected into the center of an evacuated circular chamber containing two hollow D-shaped metallic electrodes ("Dees") sandwiched between large electromagnets.

    • An alternating radiofrequency high-voltage potential rapidly flips polarity between the Dees, accelerating ions across the gap into expanding spiral orbits until they reach target energy and strike a target foil.

    • Common Cyclotron Tracers: Carbon-11 (11C^{11}\text{C}), Nitrogen-13 (13N^{13}\text{N}), Oxygen-15 (15O^{15}\text{O}), Fluorine-18 (18F^{18}\text{F}).

Schematic diagram of a cyclotron particle accelerator showing ion source, Dees, magnetic field, and target
  • Fluorodeoxyglucose (18F^{18}\text{F}-FDG) Oncology Applications:

    • 18F^{18}\text{F}-FDG is a radio-labeled glucose analog transported into cells by glucose transporters and phosphorylated by hexokinase.

    • Trapped inside hypermetabolic malignant cells (Warburg Effect), FDG uptake directly maps regional glucose consumption, allowing accurate localization of primary tumors, metastatic disease, and therapy response (e.g., pre- vs. post-chemotherapy staging in lymphoma).

  • Combined Hybrid PET/CT & SPECT/CT Systems:

    • Integrates functional PET/SPECT anatomical registration with high-resolution structural Computed Tomography (CT) in a single gantry, allowing precise attenuation correction and structural localization of abnormal metabolic activity.

Clinical Diagnostic Protocols and Scans

  • Thyroid Scintigraphy and Function:

    • Tracers: 99mTc^{99\text{m}}\text{Tc}-Pertechnetate (370 MBq370\,\text{MBq} / 10 mCi10\,\text{mCi} IV) or Iodine-123 (123I^{123}\text{I} oral).

    • Graves' Disease: Diffuse, homogenous, intensely elevated thyroid uptake throughout both lobes.

    • Toxic Multinodular Goiter: Multiple patchy areas of focal hyperuptake ("hot nodules") interspersed with suppressed parenchyma.

    • Autonomous Hot Nodule: Single hyperfunctioning nodule completely suppressing radionuclide uptake in the remaining thyroid tissue.

    • Cold Nodule: Focal area with absent uptake; carries a higher risk of thyroid malignancy requiring biopsy.

  • Pulmonary Ventilation/Perfusion (V/Q) Scintigraphy:

    • Indication: Diagnosis of Acute Pulmonary Embolism (PE).

    • Perfusion Study: Administers 99mTc^{99\text{m}}\text{Tc}-MAA intravenously to map pulmonary capillary microvascular bed flow.

    • Ventilation Study: Inhalation of Xenon-133 (133Xe^{133}\text{Xe}) gas or 99mTc^{99\text{m}}\text{Tc}-DTPA aerosol to map alveolar airways.

    • Diagnostic Finding: A classic V/Q Mismatch (normal ventilation with localized wedge-shaped perfusion defects) indicates pulmonary arterial obstruction (embolism).

  • Hepatobiliary HIDA Scintigraphy:

    • Indication: Assessment of acute cholecystitis, chronic acalculous cholecystitis, and biliary obstruction.

    • Protocol: 99mTc^{99\text{m}}\text{Tc}-HIDA is extracted by hepatocytes and excreted into the biliary tree/gallbladder. Following gallbladder visualization, a Cholecystokinin (CCK) analog is infused to stimulate gallbladder contraction.

    • Gallbladder Ejection Fraction (GBEF): Calculated post-CCK infusion. A GBEF <35%<35\% to 40%40\% is diagnostic for chronic acalculous cholecystitis, predicting clinical improvement following laparoscopic cholecystectomy.

  • Myocardial Perfusion Imaging (MPI) / Nuclear Cardiology:

    • Tracers: 99mTc^{99\text{m}}\text{Tc}-Sestamibi (Cardiolite), 99mTc^{99\text{m}}\text{Tc}-Tetrofosmin (Myoview), or Thallium-201 (201Tl^{201}\text{Tl}).

    • Protocol: Dual-phase acquisition comparing myocardial uptake images obtained during peak physical/pharmacological stress versus resting baseline.

    • Ischemia vs. Infarction: Reversible perfusion defects (normal at rest, defective during stress) indicate inducible myocardial ischemia / coronary artery stenosis. Fixed perfusion defects (abnormal on both rest and stress scans) indicate non-viable necrotic myocardial scar tissue (infarction).

Master Reference Table of Medical Radioisotopes

Radioisotope

Symbol

Half-Life (TpT_p)

Production Source

Primary Medical / Diagnostic Applications

Technetium-99m

99mTc^{99\text{m}}\text{Tc}

6.0 hours6.0\,\text{hours}

Generator (99Mo^{99}\text{Mo})

Cardiac perfusion, skeletal bone, thyroid, lung V/Q, liver/spleen, renal, brain, infection

Molybdenum-99

99Mo^{99}\text{Mo}

66 hours66\,\text{hours}

Reactor (Fission)

Parent radioisotope in Technetium-99m generator systems

Iodine-131

131I^{131}\text{I}

8.04 days8.04\,\text{days}

Reactor (Fission)

Thyroid cancer therapy (20−200 mCi20{-}200\,\text{mCi}), hyperthyroidism therapy, thyroid imaging

Iodine-123

123I^{123}\text{I}

13.2 hours13.2\,\text{hours}

Cyclotron

Pure gamma diagnostic evaluation of thyroid uptake, function, and morphology

Iodine-125

125I^{125}\text{I}

60 days60\,\text{days}

Reactor

Prostate and brain cancer brachytherapy seeds, kidney glomerular filtration rate

Fluorine-18

18F^{18}\text{F}

110 minutes110\,\text{minutes}

Cyclotron

Positron emitter in 18F^{18}\text{F}-FDG PET imaging for oncology, neurology, and cardiology

Thallium-201

201Tl^{201}\text{Tl}

73 hours73\,\text{hours}

Cyclotron

Myocardial stress/rest perfusion imaging, substitute for Technetium-99m, lymphoma imaging

Gallium-67

67Ga^{67}\text{Ga}

78 hours78\,\text{hours}

Cyclotron

Tumor localization, chronic inflammatory lesion/infection localization

Gallium-68

68Ga^{68}\text{Ga}

68 minutes68\,\text{minutes}

Generator (68Ge^{68}\text{Ge})

Positron emitter used in specialized PET-CT neuroendocrine tumor imaging

Indium-111

111In^{111}\text{In}

2.8 days2.8\,\text{days}

Cyclotron

Leukocyte labeling for abscesses/infections, neuroendocrine tumor imaging, cisternography

Xenon-133

133Xe^{133}\text{Xe}

5.24 days5.24\,\text{days}

Reactor (Fission)

Inhalation gas for pulmonary ventilation studies

Krypton-81m

81mKr^{81\text{m}}\text{Kr}

13 seconds13\,\text{seconds}

Generator (81Rb^{81}\text{Rb})

Ultra-short-lived gas for functional pulmonary ventilation imaging

Rubidium-82

82Rb^{82}\text{Rb}

1.26 minutes1.26\,\text{minutes}

Generator (82Sr^{82}\text{Sr})

Positron emitting myocardial perfusion agent in PET cardiology

Cobalt-60

60Co^{60}\text{Co}

5.27 years5.27\,\text{years}

Reactor

Industrial sterilization of medical supplies, legacy external beam teletherapy

Phosphorus-32

32P^{32}\text{P}

14.3 days14.3\,\text{days}

Reactor

Therapy for Polycythemia Vera (excess red blood cells) and chronic leukemias

Samarium-153

153Sm^{153}\text{Sm}

47 hours47\,\text{hours}

Reactor

Quadramet; targeted beta therapy for palliative relief of painful skeletal bone metastases

Strontium-89

89Sr^{89}\text{Sr}

50.5 days50.5\,\text{days}

Reactor

Metastron; pure beta therapeutic bone seeker for skeletal pain palliation

Yttrium-90

90Y^{90}\text{Y}

64 hours64\,\text{hours}

Reactor

Pure beta emitter for liver cancer radioembolization and arthritic joint synovectomy

Bismuth-213

213Bi^{213}\text{Bi}

46 minutes46\,\text{minutes}

Reactor

Targeted Alpha Therapy (TAT) for high-energy selective tumor cell killing

Carbon-11

11C^{11}\text{C}

20 minutes20\,\text{minutes}

Cyclotron

Positron emitting tracer for PET brain physiology and neuropharmacology